Data sources SEC FORM 4 4h ago
HOUSE PTR 4h ago
SEC 13F 4h ago
ROBINHOOD CHAIN 4h ago
Public company CDTX Cidara Therapeutics, Inc.CIK 0001610618
Disclosed transactions 21
Buys / sells 0 / 0
Max Insider Score 18
Connections 5 with evidence
CDTX · disclosed activity on price
Score Actor Security Side Value Executed Disclosed Lag Source Evidence 18 DN Davarpanah Nicole Negar Chief Medical Officer
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D $2.78M 12.6K sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9
DN Davarpanah Nicole Negar Chief Medical Officer
CDTX Cidara Therapeutics, Inc. Disposition to issuer
Jan 7, 2026traded Jan 7, 2026
9 DN Davarpanah Nicole Negar Chief Medical Officer
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 11.0K sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 DN Davarpanah Nicole Negar Chief Medical Officer
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 5,000 sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 DN Davarpanah Nicole Negar Chief Medical Officer
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 62.6K sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 DN Davarpanah Nicole Negar Chief Medical Officer
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 30.0K sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 DN Davarpanah Nicole Negar Chief Medical Officer
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 20.0K sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 2,125 sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 11.1K sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CC Canale-Theakston Carin Director
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 16.0K sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CC Canale-Theakston Carin Director
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 11.1K sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 4,250 sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CC Canale-Theakston Carin Director
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 1,750 sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CC Canale-Theakston Carin Director
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 875 sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CC Canale-Theakston Carin Director
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 1,400 sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CC Canale-Theakston Carin Director
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 2,125 sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CC Canale-Theakston Carin Director
CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 2,125 sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 4,250 sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 2,125 sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
9 CDTX Cidara Therapeutics, Inc. Disposition to issuer
D — 11.1K sh
Jan 7, 2026 Jan 7, 2026traded Jan 7, 2026
+0d SEC FORM 4 Evidence
Evidence Close
12 DN Davarpanah Nicole Negar Chief Medical Officer
CDTX Cidara Therapeutics, Inc. Gift
G — 450 sh
Dec 29, 2025 Dec 29, 2025traded Dec 29, 2025
+0d SEC FORM 4 Evidence
Evidence Close
Chief Medical Officer · Dec 29, 2025
Source error Price history for CDTX is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.